Cost Pressure Continues

Active pharmaceutical ingredient (API) manufacturers around the world continue to be squeezed by rising costs, and pressure from customers in the pharmaceutical industry seeking lower raw material prices. “The cost pressure on API manufacturing is intense,” says Stefan Stoffel, head of chemical manufacturing at Lonza. “This is why Lonza has put a tremendous amount of work into developing an efficient sourcing organization, lean and innovative processes, and operational excellence initiatives.” “Pharmaceutical companies are facing a...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers